KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EBT (2016 - 2025)

Labcorp Holdings' EBT history spans 17 years, with the latest figure at $190.6 million for Q4 2025.

  • For Q4 2025, EBT rose 3.7% year-over-year to $190.6 million; the TTM value through Dec 2025 reached $1.1 billion, up 15.42%, while the annual FY2025 figure was $1.1 billion, 15.42% up from the prior year.
  • EBT for Q4 2025 was $190.6 million at Labcorp Holdings, down from $337.0 million in the prior quarter.
  • Across five years, EBT topped out at $1.0 billion in Q1 2021 and bottomed at -$147.1 million in Q4 2023.
  • The 5-year median for EBT is $286.3 million (2024), against an average of $338.0 million.
  • The largest annual shift saw EBT soared 481.7% in 2021 before it crashed 117.52% in 2022.
  • A 5-year view of EBT shows it stood at $447.0 million in 2021, then plummeted by 117.52% to -$78.3 million in 2022, then plummeted by 87.87% to -$147.1 million in 2023, then surged by 224.95% to $183.8 million in 2024, then grew by 3.7% to $190.6 million in 2025.
  • Per Business Quant, the three most recent readings for LH's EBT are $190.6 million (Q4 2025), $337.0 million (Q3 2025), and $304.7 million (Q2 2025).